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The genesis for this topical review stems from the interdisciplinary Biointerfaces International con-
ference 2016 (BI 2016) in Zurich, Switzerland, wherein the need for advances in analytical tools
was both expressed and addressed. Pushing the limits of detection for characterizing individual
components, such as single proteins, single drug-delivery vehicles, or probing single living cells in
a more natural environment, will contribute to the understanding of the complex biomolecular
systems central to a number of applications including medical diagnostics, tissue engineering, and
drug screening and delivery. Accordingly, the authors begin with an overview of single nanoparticle
analytics highlighting two emerging techniques and how they compare with existing techniques.
The ﬁrst is based on single particle tracking of nanoparticles tethered to a mobile supported lipid
bilayer, enabling the simultaneous characterization of both size and composition of individual nano-
particles. The second technique is based on probing variations in the ionic conduction across nano-
scale apertures for detection of not only nanoparticles but also membrane-tethered proteins, thereby
allowing a multiparameter characterization of individual nanoscopic objects, addressing their size,
shape, charge, and dipole moment. Subsequently, the authors lead into an example of an area of
application that stands to beneﬁt from such advances in bioanalytics, namely, the development of
biomimetic lipid- and polymer-based assemblies as stimuli-responsive artiﬁcial organelles and
nanocarriers designed to optimize delivery of next generation high-molecular-weight biological
drugs. This in turn motivates the need for additional advanced techniques for investigating the
cellular response to drug delivery, and so the review returns again to bioanalytics, in this case
single-cell analysis, while highlighting a technique capable of probing and manipulating the content
of individual living cells via ﬂuidic force microscopy. In presenting a concerted movement in the
ﬁeld of bioinspired bioanalytics, positioned in the context of drug delivery, while also noting
the critical role of surface modiﬁcations, it is the authors’ aim to evaluate progress in the ﬁeld
of single component bioanalytics and to emphasize the impact of initiating and maintaining a
fruitful dialogue among scientists, together with clinicians and industry, to guide future directions
in this area and to steer innovation to successful translation. © 2018 Author(s). All article content,
except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license
(http://creativecommons.org/licenses/by/4.0/). https://doi.org/10.1116/1.5037582
I. INTRODUCTION
The interface between engineered materials and biological
systems is one of the most rapidly expanding areas of
science and technology and now encompasses medical
implants, drug delivery, regenerative medicine, and medical
diagnostics. Future progress depends strongly on the
development of new bioanalytical tools to understand these
interfaces and to develop a functional understanding of
complex biomolecular systems. The capability to both char-
acterize and quantify single nanoparticles in solution or
single proteins in their native conformation, without the need
for labeling, is of great interest and is expected to contribute
to a number of applications ranging from identifying and
sorting optimal drug-delivery vehicles to rapid and sensitive
protein detection from a complex biological medium. As an
illustrative example, next generation drug-delivery vehicles
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carrying biologicals, such as proteins or nucleic acids, are
often designed today based on information that has been gar-
nered through existing analytical techniques about how
natural biological nanoparticles, such as viruses or exosomes,
transfer genetic information between cells in vivo, including
characteristics such as remaining stable against biological
degradation, interacting weakly with serum proteins and
(nontarget) cells, reaching their target tissues with high efﬁ-
ciency, and even entering into target cells to induce the
desired functional response. When considering the complex-
ity of steps that must be precisely understood and controlled
for the development of next generation functional drug-deliv-
ery vehicles—as just one example out of a number of bio-
medical applications—it is clear that future progress depends
critically upon the development of bioanalytical tools
capable of studying single nanoparticles and biomolecular
complexes, individually, in their native environments.
Furthermore, the ability to subsequently investigate cellular
uptake and the ensuing effects on individual cells presents as
yet another area of bioanalytics for which a driver toward
higher precision and physiologically relevant in vitro cell
analysis persists.1–3
Correspondingly, this topical review will focus on recent
advances of precisely such bioanalytical tools that make use
of and contribute to our understanding of the supramolecular
assemblies found in nature to achieve new levels of detection
in the characterization of single proteins, single nanocarriers,
and in our ability to interact with single living cells. The
interdisciplinary nature of this paper is in line with, and
inspired by, the inaugural Biointerfaces International (BI)
conference 2016 in Zurich, Switzerland, that aimed precisely
at fostering cross-disciplinary dialogues spanning from aca-
demic laboratories to hospital clinics, as well as to industry.
The interested reader is encouraged to seek out the interview,
in the Appendix, of Dr. Marcus Textor, the chairman and
visionary behind the inaugural Biointerface International
2016, that further illustrates the rationale and need for this
type of open communication. Dr. Textor outlines the impor-
tance of an ever wider interdisciplinary approach to creating
biologically functional materials for both diagnostic applica-
tions, e.g., drug screening, toxicity, disease monitoring, as
well as for applications in targeted drug delivery and regen-
erative medicine. While expressing his excitement for bioin-
spired solutions, Dr. Textor further emphasizes the
importance of tackling the hurdles for translation of
advanced technology and the need for improved bioanalyti-
cal tools in enhancing both our understanding of and the
further advancements of functional materials in the medtech
ﬁeld.
Following this vision, an overview of the ﬁeld of single
nanoparticle analytics is described as the starting point, in
Sec. II, highlighting a new technique based on single particle
tracking (SPT) of membrane-tethered nanoparticles enabling
the characterization of both the size and content of single
biological nanoparticles.4 It stands as a detailed example of
the ﬁeld, which together with a review of alternative tools
used in single nanoparticle analytics, underscores the
importance of addressing nanoparticle heterogeneity with
respect to size and molecular content. In Sec. III, the focus
turns to a complementary approach based on probing varia-
tions in the ionic conduction across nanoscale apertures that
further enables not only the detection of nanoscopic entities
down to individual protein molecules but also makes it pos-
sible to characterize them with respect to, for example, their
size, shape, charge, and dipole moment,5 thus complement-
ing the method presented in Sec. II. While highly relevant
from both a purely fundamental and applied diagnostic per-
spective, the possibility to characterize the physicochemical
properties of individual nanoparticles and proteins will also
aid in our understanding of how dynamic engagement of
multiple weak intermolecular interactions could be optimized
in the assembly of supramolecular systems, as in drug-deliv-
ery vehicles, for example. Therefore, in Sec. IV, drug-deliv-
ery systems are discussed as an example of a ﬁeld that stands
to beneﬁt from the types of bioanalytical techniques pre-
sented in Secs. II and III, with a focus on the development
of biomimetic lipid- and polymer-based assemblies designed
to optimize delivery of next generation high-molecular-
weight biological drugs or to generate artiﬁcial organelles
able to act, in vivo, as cellular implants.6 Furthermore, the
successful translation to clinical use of these advanced drug-
delivery systems and artiﬁcial organelles will depend on
extensive evaluations, thus leading us into Sec. V wherein
the most promising analytical tools for single-cell analyses
(SCA) are presented with a particular focus on a technique
based on probing and manipulating the content of an individ-
ual cell through ﬂuidic force microscopy.7 We close the
paper with an outlook of the most crucial bottleneck issues
involved in quantitative nanoparticle analysis, with particular
emphasis on the importance of sophisticated surface modiﬁ-
cations for these tools to function properly, and the need not
only to analyze heterogeneous samples with single nanopar-
ticle resolution but also to sort and enrich with the same
single molecule precision. Furthermore, a perspective on the
obstacles to commercialization is presented along with a dis-
cussion of the need for biologically designed tissue engi-
neered organoid model systems, combined with suitable
analytical tools, to act as in vitro disease models for studying
disease biology, drug development, and human toxicity.
II. SINGLE NANOPARTICLE ANALYTICS AND 2D
FLOW NANOMETRY
Molecular self-assembly, governed by weak intermolecu-
lar interactions, has evolved as a central design principle of
small-scale supramolecular assemblies, including viruses and
membrane-enveloped biological nanoparticles, such as exo-
somes, that participate in intercellular communication.8
Obviously, the design of biomimetic drug-delivery nanocar-
riers, as schematically illustrated in Fig. 1, is aimed at per-
forming similar tasks to that of exosomes or viruses and is
therefore very demanding as it requires exact control of mul-
tiple precisely ﬁne-tuned supramolecular self-assembly pro-
cesses.6,9,10 The magnitude of this challenge becomes ever
040801-2 Grandin et al.: Bioinspired, nanoscale approaches in contemporary bioanalytics 040801-2
Biointerphases, Vol. 13, No. 4, Jul/Aug 2018
more clear by considering that, despite signiﬁcant research
efforts, the interdependent roles of particle dimension, struc-
ture, shape, and ﬂexibility with respect to the type of binder,
density, and accompanied multivalent binding for efﬁcient
cellular uptake and cellular response still remain largely
unknown.11 For example, both cellular uptake and functional
response of cells targeted by biological nanoparticles are
known to depend on nanoparticle size, ligand density,12
shape,13 and molecular composition, which in turn depend
on the physicochemical properties of the individual compo-
nents and their relative concentration as well as preparation
method.3,14–16 Progress in this ﬁeld is thus strongly depen-
dent on developing the ability to characterize the exact physi-
cochemical properties of both natural and artiﬁcially
produced bioinspired nanocarriers.
Methods conventionally used to characterize soft biologi-
cal nanoparticles can be divided according to the nature of
the information they provide. Depending on the application,
it is also important to consider whether they provide single
nanoparticle or ensemble-averaging information. In Table I,
the most commonly used nanoparticle characterization
methods, with single nanoparticle resolution, are categorized
according to the resolution they offer, with respect to the
smallest detectable size, together with a rough indication
regarding the required concentration and total sample
volume needed to reach sufﬁcient resolution and statistics.
Here, we will focus on methods offering single nanoparticle
resolution; however, we acknowledge the value of ensemble-
averaging methods, such as dynamic light scattering (DLS)17
and neutron and x-ray scattering,18 when used to analyze
molecularly homogeneous samples with narrow size distribu-
tions, in which case the physical and structural information
provided is often superior compared with that offered by
methods with single nanoparticle sensitivity. For example,
DLS can in such cases offer not only precise size determina-
tions but also accurate zeta-potential and concentration deter-
minations.19 Neutron and x-ray scattering techniques, in
contrast, offer very detailed structural information, as, for
example, recently illustrated by Lindfors et al., when
showing that successful mRNA delivery is critically depen-
dent not only on nanoparticle size but also on structure.20
Further, ensemble-averaging surface analytical tools, such as
quartz crystal microbalance, ellipsometry, and surface
plasmon resonance (SPR), can provide an accurate determi-
nation of the nanoparticle size by quantifying the thickness
of ﬁlms made up of nanoparticles.21,22 In particular, by mod-
ifying the surface with antibody binders, even heterogeneous
biological nanoparticles can be analyzed via selective
binding of subpopulations characterized by carrying certain
biological markers,23 and the concentration can also be deter-
mined from the rate of binding.22 In many situations,
however, the heterogeneous nature of nanoparticles severely
limits the applicability of ensemble-averaging methods. For
example, although it has been known for more than a decade
that extracellular vesicles (EVs) can communicate genetic
information between cells,24 it was not until recently that it
has become clear that it is only a very minute fraction of all
cell-produced EVs that has the size, molecular composition,
FIG. 1. Schematic illustration of nanoparticle binding to a cell membrane utilizing different ligands directed to different cell-membrane receptors, followed by
uptake, endosomal release, and a functional response.
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and content required to be taken up by and subsequently
reprogram neighboring cells. Similarly, for many types of
viruses, it is well established that only a small fraction are
infectious and thus capable of spreading disease.25
Providing analytical information about single biological
nanoparticles has traditionally been restricted to electron
microscopy (EM), which offers a resolution that approaches
the detection limit in terms of nanoparticle size of many
ensemble-averaging methods (see Table I). Soft biological
nanoparticles of heterogeneous nature can be analyzed using
transmission EM (TEM), providing information about both
dimension and structure of individual nanoparticles; however,
the transfer of the nanoparticles to a solid substrate and the
staining required prior to analysis under vacuum conditions
tend to cause structural alterations that complicate proper anal-
ysis.26 Cryo-freezing prior to TEM (cryo-TEM) analysis is
thus strongly preferred in order to obtain representative struc-
tural information of soft nanoparticles.27 An additional and
particularly valuable asset of TEM is the possibility to
combine structural and dimensional heterogeneities with gold
nanoparticle labeling of speciﬁc biomolecular entities, e.g.,
immune-gold labeling. In a recent study by Brisson et al.,
cryo-TEM was successfully combined with both antibody
and annexin-V labeled gold nanoparticles,28 making it possi-
ble to, for example, identify subpopulations of certain struc-
tures and sizes exposing either a speciﬁc protein receptor or
phosphatidylserine lipids or both. Although high-resolution
cryo-TEM is quite informative, it remains a challenge to
obtain instantaneous information with high throughput in a
convenient manner. In addition, the analysis is costly and
must often be carried out in shared microscopy centers and
suffers from limitations with respect to low statistics and com-
plications arising as a consequence of, often cumbersome,
preparation protocols.
In contrast to EM, atomic force microscopy (AFM) can be
carried out at room temperature and in the wet state, but the soft
nanoparticles must be immobilized to an interface prior to
analysis. Although one must keep in mind that both surface
immobilization and the close proximity between the sample
and the tip used for imaging may impact structural integrity,
liquid-phase AFM has been shown to provide information
about topography as well as mechanical and chemical proper-
ties of soft nanoparticles.29–31 Further, by modifying the AFM
tip such that it interacts speciﬁcally with biomarkers on the
surface of nanoparticles, it has been veriﬁed that force spec-
troscopy curves could discriminate different subpopulations
of extracellular vesicles.31 By modifying the substrates with
binders, such as antibodies, directed against markers on the
surface of biological nanoparticles, one should, in analogy
with ensemble-averaging surface-sensitive methods such as
SPR (Ref. 32) or nanoplasmonics,23,33 be able to identify spe-
ciﬁc subpopulations of nanoparticle suspension via selective
binding to the surface. However, quantiﬁcation of the concen-
tration of surface markers on biological nanoparticles is not
straightforward with any of these approaches. Furthermore,
despite offering valuable biophysical and structural insights,
AFM suffers, much like EM, from cumbersome preparation
protocols and extended analysis times. As a consequence,
statistics are often based on a low sample size, which has a
direct inﬂuence on the ability to address statistical distribu-
tions in heterogeneous samples. Although the number of
particles that should be analyzed to gain sufﬁcient statistics
with either EM, AFM, or alternative single nanoparticle tools,
varies widely depending on the information one strives for, it
generally requires somewhere in the range of a couple of
hundred to a few thousand particles. As this is often time con-
suming to obtain using AFM and EM, and as this is an aspect
of signiﬁcant importance in single nanoparticle analytics, the
need for alternative bioanalytical tools offering immediate
information and good statistics persists.
Thanks to ease of use and the capacity to provide a wide
range of detailed information, optical microscopy has
become the most important imaging method in all of life
science. With appropriate labeling strategies, ﬂuorescence
TABLE I. Summary of the most commonly used commercially available methods for single nanoparticle analytics.
Single nanoparticle methods Physical parameters determined
Size in
diameter Concentration (volume)d
Electron microscopy (EM)
cryo-frozen solution based
Size, shape ∼1–10 nm 1012–1014 particles/ml (∼2 μl)
Nanoparticle tracking analysis (NTA)
solution based
Hydrodynamic diameter, charge, optical fingerprint,a
concentrationb
∼30–60 nm 107–109 particles/ml (∼750 μl)
Resistive pulse sensing (RPS)
solution based
Size, charge, electrical fingerprint,c concentration ∼30–60 nm 107–109 particles/ml (∼1 ml)
Flow cytometry
solution based
Size, optical fingerprints, concentration ∼50–100 nm 107–109 particles/ml (∼1 ml)
Optical microscopy
surface based
Optical fingerprint ∼5–40 nm 1011–1013 particles/ml (10–100 μl)
aOptical fingerprint refers to the possibility to identify one or several components of the nanoparticles using, e.g., fluorescent markers.
bRequires that all nanoparticles with a known volume generate a detectable signal.
cSee Sec. III.
dSince the concentration can usually be controlled by either diluting or concentrating the sample, we here provide both the typical concentration and sample
volume used in a single analysis.
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microscopy contributes invaluable information regarding the
biological impact of nanoparticles; however, whether of bio-
logical origin or not, nanoparticles are not naturally labeled
with ﬂuorophores, and incorporation of labels inevitably
adds an additional preparative step and might inﬂuence their
properties and function. Means to perform label-free optical
single nanoparticle analysis is thus of high importance but,
due to their very weak optical contrasts, this is a very
demanding task. In order to utilize light scattering in nano-
particle analysis, it is a prerequisite to efﬁciently suppress
background scattering, which can be most easily achieved by
letting the nanoparticles diffuse freely in a perfectly dust-free
aqueous solution. Modern optics, then, makes it possible to
image and track the motion of individual nanoparticles while
diffusing through a volume illuminated by a collimated light
beam. Under the assumption that all nanoparticles in a
known illumination volume are detected, it is possible to
quantify both concentration34 and size;35 the latter by deter-
mining the diffusion constant (∝1/radius) from SPT analysis.
For example, despite not being able to detect optically faint
and small (radius <∼20 nm) particles, nanoparticle tracking
analysis (NTA) has been shown to provide accurate informa-
tion about the hydrodynamic size as well as size distribution
of heterogeneous samples. Combined with ease of use and
low sample consumption, see Table I, this explains the
growing popularity of NTA over the past couple of years.
NTA has been shown to correlate very well with alterna-
tive methods designed for size determination of individual
nanoparticles, such as tunable resistive pulse sensing
(TRPS),36 which in analogy to the nanopore sensing concept
developed by Mayer et al. (described further in Sec. III)
takes advantage of the temporal evolution of a resistive pulse
in an ionic current generated upon passage of individual sus-
pended nanoparticles across a nanoscale aperture in a thin
membrane. In analogy with immunogold labeling combined
with EM analysis, it is possible to implement NTA not only
in scattering but also in ﬂuorescence mode such that molecu-
lar labeling approaches (e.g., immuno-labeling) can enable
the identiﬁcation and analysis of biomolecular nanoparticles
with speciﬁc molecular content.37 In this way, molecular ﬁn-
gerprinting can be correlated with nanoparticle size; for
instance, the size of CD63 positive EVs derived from human
mast cells was shown to have a size distribution of around
80 nm, which was signiﬁcantly smaller than the mean size of
∼200 nm of the corresponding EVs determined in scattering
mode.22 In future designs by implementing multispectral ﬁn-
gerprinting, which is today routine in ﬂow cytometry analy-
sis of cells, the biological signiﬁcance of this mode of
operation will further increase as it will harness the capacity
for combinatorial ﬁngerprinting. The current version of NTA
has one signiﬁcant drawback, however, which is that the
nanoparticles under analysis diffuse in and out of a colli-
mated illumination beam, thus making the intensity of the
emitted light subject to signiﬁcant ﬂuctuations. Therefore,
quantitative determination of the scattering intensity and/or
the ﬂuorescence emission becomes very uncertain, thereby
complicating the possibility to quantify, on the single
nanoparticle level, the molecular content and its correlation
with particle size.38–40
To address the latter challenge, Höök et al. have devel-
oped, as presented at BI 2016, a method for making it possi-
ble to simultaneously quantify both the size and the
molecular content of individual nanoparticles.4 The concept
utilizes the surface localization and reduction in diffusivity
obtained by tethering nanoparticles to a ﬂuid supported lipid
bilayer (SLB), which fulﬁlls the purpose of conﬁning the
mobile nanoparticles to the focal plane for optimal micro-
scopic visualization. In this method, referred to as 2-dimen-
sional nanometry, both the ﬂuorescence emission and
scattering intensities (possible by suppressing interfacial
scattering) can be determined with high accuracy,41 which is
illustrated in Fig. 2 for ﬂuorescently labeled lipid vesicles
(see legend to Fig. 2 for details).
By also inducing a directed motion of the tethered nano-
particles using a shear ﬂow, the force acting on the nanoparti-
cles can be quantiﬁed from their directed drift velocity since
the drag (inversely proportional to the diffusivity) represents
the proportionality constant between force and velocity.
Hence, owing to the possibility to decouple the stochastic
Brownian motion [y-axis in Fig. 3(b): diffusivity] of individ-
ual nanoparticles from their deterministic shear-ﬂow-induced
motion [x-axis in Fig. 3(b): velocity], microscopic visualiza-
tion and SPT analysis of nanoparticles tethered to a supported
lipid bilayer was shown to enable determinations not only of
optical ﬂuorescent ﬁngerprints but also of the force acting on
them. Furthermore, since the dependence of the measured
force on the size of the nanoparticles can be expressed analyt-
ically,40 the individual nanoparticle size could be determined
with high accuracy in a diameter interval of 30–300 nm.
Further, in this interval the ﬂuorescence intensity of individ-
ual lipid vesicles was indeed shown to display signiﬁcantly
better agreement with particle size than that obtained for the
same particles using NTA [Fig. 3(c)], potentially opening up
a new avenue in single nanoparticle analytics.
Previously, correlations between nanoparticle size and
ﬂuorescence intensity have been reported for artiﬁcial lipid
vesicles, in which case one type of ﬂuorescently labeled
lipid was used to report on particle size (ﬂuorescence emis-
sion∝ r2) and another to report on molecular content. Even
for synthetic lipid vesicles, surprisingly large heterogeneities
in molecular (lipid) distribution were reported using this
approach.42 In fact, the 2D ﬂow nanometry data shown in
Fig. 3 suggest that there is a signiﬁcantly lower heterogeneity
than previously reported and thus indicates that independent
determinations of nanoparticle size and molecular composi-
tion offer improved analytical precision; a feature that will be
even more relevant in the case of biologically derived nano-
particles for which it is hard to identify the marker needed to
report on their size. While size and molecular content of
individual nanoparticles in heterogeneous samples are obvi-
ously very relevant parameters, even more would be gained
if additional properties, such as shape and charge, could be
simultaneously determined. In fact, as summarized in
Sec. III, recent advances in nanopore sensing have been
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recently shown to provide exactly this not only for biological
nanoparticles but also for individual protein molecules.
III. SINGLE PROTEIN ANALYTICS: NANOPORE-
BASED RESISTIVE PULSE SENSING
To improve the limit of detection in medical diagnostics
and in routine protein assays, the ultimate vision would
be a quantitative and descriptive analysis of individual
proteins in complex mixtures without the need for antibodies
or other afﬁnity reagents as selective capturing agents.
Characterization, identiﬁcation, and quantiﬁcation of individ-
ual proteins in complex solutions without the use of speciﬁc
labeling strategies is, however, extremely demanding. State-
of-the-art mass spectrometry, which is arguably the most
powerful technique for label-free protein analysis,43–45
requires femtomole amounts (10−15 mol) of proteins for
accurate detection and can therefore not provide information
about the structure or shape of individual proteins. The only
techniques that can reveal detailed shape information from
single proteins and protein complexes are cryo-transmission
electron microscopy (cryo-TEM or cryo-EM) and to a lesser
extent AFM has been explored for imaging protein structure
in a physiological medium. Among these, cryo-EM has
proven capable of unraveling protein structures at atomic res-
olution—an astonishing feat that has been recognized with
the Nobel Prize in Chemistry in 2017. However, cryo-EM
typically determines protein shape from class averages
obtained from analysis of several thousand randomly ori-
ented particles from a pure sample; the method therefore ana-
lyzes individual proteins but the ﬁnal result originates from
averages of many proteins.46,47 AFM, on the other hand, can
provide image and shape information from single proteins
and oligonucleotides; however, the biomolecules of interest
have to be immobilized on an atomically ﬂat surface and,
due to the ﬁnite sharpness of AFM tips, the resolution of the
FIG. 2. Schematic representation of the planar waveguide chip and detection of ﬂuorescently labeled vesicles in ﬂuorescence and scattering modes. (a) A single
mode optical ﬁber was aligned to the facet of the planar waveguide and light (green) was coupled into the core layer of the chip. An opening (sample well)
was formed in the upper cladding layer of the waveguide, into which a solution (drop) containing the specimen of interest was placed. The evanescent part of
the in-coupled light interacts with objects present within the penetration depth of the evanescent light resulting in light scattering and, in the case of ﬂuorescent
objects, ﬂuorescence generation. The emitted light was collected using a standard microscope objective in an upright or inverted conﬁguration, or a combina-
tion of both, to reveal a scattered signal in the scattering image plane (green square) and/or a ﬂuorescence signal in the ﬂuorescence image plane (red/orange
square). (b) Fluorescence and (c) scattering signals from the same 12 × 12 μm2 area of the chip under identical illumination conditions, showing nominally
150 nm ﬂuorescently labeled vesicles bound to the surface imaged with high- and low-pass ﬁlters, respectively, with cutoff wavelength of around 550 nm, i.e.,
in between the excitation (532 nm) and emission (582 nm) wavelengths. The scale bar in (c) corresponds to 2 μm. (d) Scattering and ﬂuorescence intensities
from single vesicles. Scaling with the powers 1/4 and 1/2 for 2000 single ﬂuorescently labeled vesicles with an average diameter of 150 nm. The plot is
expected to be linear provided Is∝ r4 and If∝ r2. The distributions of the scattering (green) and ﬂuorescence (red) intensities have been projected onto the y
and x-axis, respectively, and correspond to the size distribution of the vesicles. The red vertical and green horizontal dashed lines indicate the limit of detection.
The black straight line, red dashed curve, and blue dotted curve show the theoretically predicted behavior. Adapted with permission from B. Agnarsson, et al.,
ACS Nano 9, 11849 (2015). Copyright 2015, American Chemical Society.
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technique is limited to revealing the location of local
domains rather than atomic structure.48,49 Other techniques
for determining the shape of proteins such as x-ray crystal-
lography,50 analytical ultracentrifugation,51 NMR spectro-
scopy,52 or short angle x-ray scattering53 either require a
protein crystal or are ensemble techniques, which are limited
to determining parameter averages. Further, with the excep-
tion of analytical ultracentrifugation, all these techniques
require samples of extremely pure protein and their perfor-
mance decays with increasing size of the protein, protein
complex, or nanoparticle.
Based on these limitations, there exists a need for
broadly accessible techniques to characterize single particles
ranging from individual protein molecules to hierarchical
nanoparticle assemblies with regard to their size, shape,
and state of assembly. An important step towards the possi-
bility to detect and discriminate different types of proteins
was demonstrated by Mayer et al., as presented at the BI
2016 meeting, thereby allowing not only the charge, size,
and rotational diffusion coefﬁcient of individual proteins to
be simultaneously determined but also an approximation of
their molecular shape and dipole moment. Importantly,
these characterizations occurred in aqueous solution under
nondenaturing conditions.5,54 As Fig. 4 illustrates, the
approach is based on probing temporal changes in the ionic
conductance across nanoscale apertures during passage of
individual molecules, a concept that was so far primarily
used for DNA sequencing applications, as recently
reviewed,55–57 as well as for nanoparticle analysis using
TRPS.36 In contrast to sequencing DNA, which thus far
employs biological nanopores through integral transmem-
brane proteins with diameters smaller than 2 nm, characteri-
zation of folded, globular proteins requires larger pore
diameters in the range of 5–50 nm typically fabricated in
silicon nitride membranes.5,58 One challenge with inorganic
substrate materials is, however, adsorption of proteins to the
nanopore walls. To minimize these interactions, inspiration
was gained from nanopores in the exoskeleton of insects
[Fig. 4(a)] by coating the walls of the nanopores with a ﬂuid
SLB54 and is discussed further in Sec. VI. In analogy with
the 2D ﬂow nanometry method presented in Sec. II, the two-
dimensional ﬂuidity of the SLB provides, on the one hand, a
nonstick, nonfouling surface59 and, on the other hand, the
opportunity to include lipid anchors to which suspended pro-
teins, typically in a nanomolar concentration range, can be
tethered via ﬂexible linkers [Fig. 4(b)].54 For instance, lipids
displaying biotin groups on their headgroups make it possi-
ble to capture, concentrate, and analyze biotin-binding pro-
teins on the surface.54 This concept was also extended to a
sandwich assay in which lipid-anchored streptavidin was
used to bind a commercially available, biotinylated anti-cata-
lase antibody in order to speciﬁcally capture and quantify
catalase, thus illustrating the capacity to be expanded to a
multitude of proteins.
FIG. 3. (a) Small unilamellar vesicles (SUVs) linked to an SLB at the ﬂoor of a microﬂuidic channel by cholesterol equipped DNA tethers subjected to a shear
ﬂow in a microﬂuidic channel. (b) Single particle tracking analysis provides information about diffusivity (number of linkers) and shear-induced drift velocity.
(c) Comparison of vesicle intensity extraction done by 2D ﬂow nanometry and NTA using intensity versus size parameter plots obtained by NTA (gray dots)
and 2D ﬂow nanometry (black dots) for SUVs. Thanks to much lower intensity ﬂuctuations observed in 2D ﬂow nanometry with respect to NTA, the expected
scaling law (∝r2) is well visible in the parameter plots [solid line in (c)], while it is hard to resolve for NTA data. Adapted with permission from S. Block,
B. J. Fast, A. Lundgren, V. P. Zhdanov, and F. Höök, Nat. Commun. 7, 12956 (2016). Copyright 2016, Nature. See also Creative Commons Attribution 4.0
International License, https://creativecommons.org/licenses/by/4.0/.
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Since nanopore experiments are based on the exclusion of
conducting electrolyte by any particle in the pore [Fig. 4(c)],
this technique is not limited to the analysis of monomeric
proteins; it extends to multimeric proteins,5 protein
complexes,5,59,60 viruses,61 and nanoparticles.62 To perform
a meaningful analysis of current modulations during a resis-
tive pulse from the translocation of a single protein or parti-
cle, it is, however, critical that these current modulations are
resolved in time and that the supramolecular complex resides
in the pore sufﬁciently long to adopt various orientations
before it exits.5 This requirement is met by taking advantage
of the viscosity of the ﬂuid lipid bilayer coating on the nano-
pore walls. Speciﬁcally, the lipid anchor slows down particle
translocation due to increased drag by the approximately
100-fold higher viscosity of lipid bilayers compared to the
viscosity of the aqueous electrolyte.5,54 Using this lipid
anchoring approach, the Mayer group recently demonstrated
that the passage time through the nanopore can become sufﬁ-
ciently prolonged to time-resolve modulations of ionic cur-
rents that are related to protein shape and orientation. This
ﬁne structure of resistive pulses can be correlated with multi-
ple protein properties, including volume, shape, rotational
diffusion coefﬁcient, charge, and dipole moment.5
Figure 4(c) shows an experimental setup for nanopore-
based resistive pulse recordings from translocations of single
proteins through the pore and serves to illustrate the concept
of characterizing individual nanoparticles. This setup con-
tains two reservoirs that are ﬁlled with aqueous electrolyte
solution and separated by a thin, insulating membrane. Low-
impedance Ag/AgCl electrodes in both reservoirs connect
them to a high gain, low-noise ampliﬁer that applies a cons-
tant potential difference while measuring the ionic current
through the nanopore. The crucial concept of this single mol-
ecule technique is that almost the entire voltage drop in the
conducting pathway occurs inside the nanopore, rendering
this zone supremely sensitive to changes in its ionic conduc-
tivity. Any particle entering this volume displaces highly
conducting electrolyte and increases the pore’s resistance
during its translocation. If the pore volume is on a similar
size scale as the volume of individual proteins or nanoparti-
cles of interest, then the resulting reduction in current ampli-
tude from the baseline current, ΔI, is readily detectable.
For spherical particles, the current blockade ΔI is directly
proportional to the electrolyte volume excluded by the parti-
cle and as long as a particle’s volume is sufﬁciently large to
displace at least 1% of the electrolyte volume in the pore, it
is detectable. This means that the detection limit with regard
to the smallest detectable proteins or particles can be
adjusted by appropriate choice of the nanopore volume. For
instance, pores in biological ion channel or porin proteins
with diameters close to 1 nm have been used to detect indi-
vidual small organic molecules without the requirement of
labeling these molecules.63 Figure 5 demonstrates this
concept on the level of single virus particles, gold nanoparti-
cles, and protein amyloids. For virus particles, nanopore-
based resistive pulse sensing can be used to characterize
individual viruses with regard to size, time-dependent
increase in size upon binding of antibodies, binding constant
of these antibodies on the native virus particle in solution,
and number of epitopes on the virus surface [Figs. 5(a) and
5(b)].61 Based on these capabilities, and those above, it is
FIG. 4. Bioinspired nanopore with ﬂuid lipid bilayer coating to facilitate the
movement of single molecules or nanoparticles through the pore combined
with characterization of the particle based on resistive pulse recording. (a)
Nanopores through the exoskeleton of the silk moth Bombyx mori are coated
with a ﬂuid lipid or wax coating to facilitate the capture and diffusion of phero-
mone molecules toward receptors on the dendrites in the antennae of the moth.
(b) Cartoon of a cross-section through a solid state nanopore fabricated in a
silicon nitride window and coated with a supported phospholipid bilayer. The
layer in light blue indicates the water layer between the solid substrate and the
lipid bilayer membrane. Lipid anchors (dark blue spheres) capture and concen-
trate speciﬁc proteins on the surface. (c) Experimental setup of a resistive pulse
recording experiment and typical resistive pulse signal from translocation of a
spherical particle through the nanopore. The presence of a particle in an elec-
trolyte-ﬁlled pore displaces conducting electrolyte and transiently reduces the
absolute magnitude of the baseline current through the pore. The amplitude of
the current blockade ΔI is proportional to the volume of the particle, the dura-
tion of the blockade is inversely proportional to the charge of the particle and
the frequency of blockades is proportional to the concentration of the particle.
Adapted with permission from E. C. Yusko et al., Nat. Nanotechnol. 6, 253
(2011). Copyright 2011, Springer Nature. Also adapted from E. C. Yusko
et al., Nat. Nanotechnol. 12, 360 (2017). Copyright 2017, Springer Nature.
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possible to imagine the richness of information about indi-
vidual nanoparticle size, structure, and content that could
potentially emerge by combining the approaches of Mayer
and Höök on the same chip; the slower motion caused by
tethering nanoparticles to a supported membrane extends
the duration of the passage time through a pore, thereby
increasing signal-to-noise, which could enable structural
information to be directly correlated with complementary
information about hydrodynamic size and nanoparticle
content obtained using 2D ﬂow nanometry (see Sec. II).
Self-assembled nanoparticles are often heterogeneous in
size, shape, and content, rendering ensemble-based analysis
techniques such as DLS inefﬁcient for their characterization,
as discussed in Sec. II. A dramatic example of heteroge-
neous particles are protein amyloids, which are relevant in
the context of several neurodegenerative diseases such as
Alzheimer’s and Parkinson’s disease [Fig. 5(d)]. In order to
interrogate heterogeneous samples, the nanopore-based
characterization approach takes advantage of two character-
istics: ﬁrst, the ultrasmall sensing zone, which can only
accommodate one or a few particles at a time and, second,
the short translocation time through this small volume,
which is on the order of microseconds. This short transloca-
tion time combined with an average translocation frequency
of approximately 10 Hz means that the probability of two
particles entering the sensing volume at the same time is
very low. In addition, the translocation frequency can be
reduced by diluting the analyte to further reduce the proba-
bility for double occupancy in the pore. On the other hand,
if two or more particles or molecules interact with each
other to form a complex, then these complexes will enter
the pore as one particle and we showed previously that such
complexes remain intact under typical experimental condi-
tions.5 In the case of weak interactions, this may not be the
case and the disassembly of such complexes may occur
during the actual translocation event. By probing multiple
events of this nature, it may thus be possible to investigate
the dynamics of weak complexes by monitoring, during
each translocation event, for instance, the shape of particles,
which is likely to change dramatically during disassembly.
These examples illustrate that the single particle analysis
capability of nanopore-based experiments offers new oppor-
tunities for in-depth characterization of the heterogeneity of
engineered nanoparticles and shows promise for characterizing
FIG. 5. Nanopore-based analysis of virus particles, gold nanoparticles and protein amyloid aggregates. (a) Resistive pulses before and after addition of antise-
rum to a solution of viruses make it possible to quantify their size with and without antibody coating. (b) Monitoring the time-dependent increase in antibody
size upon antibody binding reveals the afﬁnity of the antibody on intact virus particles in solution and determines the maximum number of antibodies that can
bind to a virus particle. (c) Comparison of the size distribution determined in solution with nanopore-based analysis (blue) with the size distribution of the
same sample determined by electron microscopy (red and inset). (d) Nanopore-based resistive pulse analysis of amyloid-beta (Aβ) aggregates showing the
increasing amplitude of resistive pulses as the aggregates grow during the analysis. The inset illustrates that amyloids can only be characterized in a solid state
nanopore if the walls are coated with a nonstick ﬂuid lipid bilayer coating (otherwise the pore would clog within seconds). Adapted with permission from J. D.
Uram, K. Ke, A. J. Hunt, and M. Mayer, Small 2, 967 (2006). Copyright 2006, John Wiley and Sons. Also adapted with permission from E. C. Yusko et al.,
Nat. Nanotechnol. 6, 253 (2011). Copyright 2011, Springer Nature.
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the complex, hierarchical assemblies that are often required for
targeted drug delivery.
In addition to determining the volume of viruses and pro-
teins, nanopore-based resistive pulse sensing can also be
used to determine the approximate shape of individual pro-
teins.5 To do so, the approach takes advantage of the
Brownian rotational dynamics of particles inside the nano-
pore. As shown in Fig. 6(a), a lentil-shaped object (oblate)
distorts the electric ﬁeld lines more signiﬁcantly if its ﬂat
side is oriented perpendicular to the pore axis, and hence the
electric ﬁeld, than when it is oriented parallel to the pore
axis. Similar arguments can be made for a rugby ball shaped
object (prolate), which also causes the largest current block-
ade in its cross-wise orientation. The magnitude of the parti-
cle-induced current blockade is therefore a function of
protein volume, protein shape, and time-variant protein ori-
entation during its journey through the pore.5 By time-depen-
dent analysis of the ΔI signal as a particle moves through the
pore, the approach makes it possible to determine the change
in orientation over time, revealing the rotational diffusion
coefﬁcient in addition to the particle’s volume and ellipsoid
approximation of its shape.
Moreover, since the orientation of a particle in the
extremely strong electric ﬁeld (∼MVm−1) inside a nanopore
is biased by the permanent dipole moment of the protein or
particle, analysis of this bias in orientation during transloca-
tion reveals the magnitude of the particle’s dipole.5 Since
established approaches to measure dipole moments of pro-
teins, such as dielectric impedance spectroscopy are limited
to ensemble measurements,65 precise determinations of the
dipole moments of individual proteins and nanoparticles
could add valuable information regarding heterogeneity orig-
inating from, for example, various post-translational modiﬁ-
cations such as phosphorylation and glycosylation. Although
dipole interactions are weak, the dipole moment may indeed
be an undervalued descriptor for particles and proteins. For
example, the absolute protein dipole moments range from
zero to a few thousand Debye among different proteins.5
Hence, dipole moment, if measured with sufﬁcient precision,
could offer a more powerful protein discriminator than net
charge, which typically remains within 10–20 unitary
charges.5 Despite its weak and short-range nature, the dipole
moment is also an important parameter to consider in molec-
ular assemblies, since dipole alignment and interactions are
known to inﬂuence the orientation of molecules and the
stability of assemblies as well as the rheological properties of
solutions of these particles.5
While nanopore-based resistive pulse recordings offer a
unique means to determine the dipole moment of nanoparti-
cles, these experiments also enable determination of the net
charge. Instead of measuring the drift velocity of proteins
and nanoparticles when subjected to an electric ﬁeld, this
analysis considers the time it takes for a particle to translo-
cate the length of the nanopore, which is called dwell time,
td, and related to the particle’s electrophoretic mobility and
hence its net charge.5 Nanopore-recording can therefore
characterize single proteins and nanoparticles in aqueous sol-
ution with regard to ﬁve parameters that are relevant for
FIG. 6. Analysis of current modulations while particles translocate and rotate through a nanopore makes it possible to determine the volume, shape, dipole
moment and rotational diffusion coefﬁcient of the particle. (a) Nonspherical particles modulate the resistance of a nanopore as a function of the shape and ori-
entation of the particle in the electric ﬁeld of the nanopore. (b) Comparison of the crystal structure of ﬁve proteins (red) with an ellipsoid approximation of
their shape as determined by single molecule nanopore recordings (blue). [(c)–(f )] Comparison of the particle volume, shape, dipole moment and rotational dif-
fusion coefﬁcient measured in a nanopore with reference values, illustrating good agreement. Adapted with permission from E. C. Yusko et al., Nat.
Nanotechnol. 12, 360 (2017). Copyright 2017, Springer Nature.
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supramolecular assemblies: volume, shape, rotational diffu-
sion coefﬁcient, dipole moment, and charge. The ﬁdelity
of this multiparameter characterization is illustrated in
Figs. 6(c)–6(f), which shows the correlation between the
measured particle volume, shape, dipole moment, and rota-
tional diffusion coefﬁcient with the corresponding reference
values.
With regard to the characterization of nanoparticles and
supramolecular assemblies, this section and the 2D ﬂow
nanometry concept presented in Sec. II illustrate that
methods are emerging with certain advantages for determina-
tion of multiple parameters providing a ﬁngerprint analysis
of individual nanoparticles and rare biological molecules in
complex and aqueous solutions (Fig. 6). In this context, it is
important to realize that the parameters, which make up the
ﬁngerprint, are obtained simultaneously from each resistive
pulse when a single protein or a single protein complex
translocates through the nanopore.5 For instance, the time-
averaged magnitude of the resistive current blockade is pro-
portional to the volume of the particle, the duration of the
resistive pulse to the net charge of the particle, the current
“noise” during the resistive pulse is related to the particle’s
shape and orientation in the electric ﬁeld, the frequency of
these current modulations to its rotational diffusion coefﬁ-
cient, and the bias in these modulations towards one orienta-
tion to its dipole moment.5 Changes in particle properties
such as volume, shape, or charge can therefore be deter-
mined unambiguously because the various measured proper-
ties relate differently to these particle properties. These
novel, single particle characterization approaches therefore
yield the stoichiometry of assemblies, the number of accessi-
ble surface groups or epitopes, the kinetics of assemblies
and disassemblies, the stability of complexes, and a low-res-
olution ellipsoid approximation of their shape as required to
design and optimize, for example, supramolecular assemblies
of next generation drug-delivery vehicles.60,61 While living
cells excel at assembling macromolecular subunits to func-
tional delivery systems in the form of exosomes or viruses,
engineering artiﬁcial nanoparticles with these capabilities is
challenging because of multiple possible failure points on
the assembly trajectory. Thus, progress in designing and fab-
ricating such hierarchically assembled nanoparticles reliably
in bulk, as required for therapeutic use, requires accurate and
fast techniques for quality control. The need for such pro-
gress in nanoparticle analytics is further illustrated in
Sec. IV, which places emphasis on recent advancement in
the design of stimuli-responsive synthetic polymer-based
nanoparticles designed for either oligonucleotide/protein
delivery or to function as artiﬁcial organelles.
IV. BIOMIMETIC DRUG-DELIVERY ASSEMBLIES
AND ARTIFICIAL ORGANELLES
Conventional low-molecular-weight drugs typically
execute their tasks by interacting with and thereby inﬂuenc-
ing the function of speciﬁc proteins or by detoxifying
harmful agents inside cells, while the next generation drugs
are expected to be increasingly based on high-molecular-
weight biologicals designed to reprogram the cells from
within,14,66 as well as being based upon functional supramo-
lecular biosynthetic assemblies intended to serve as cellular
implants such as artiﬁcial organelles.6,67 In contrast to con-
ventional drugs, but in analogy with the genetic cargo
carried by exosomes and viruses, many of these biological
drugs (peptides, proteins, oligonucleotides, etc.) do not
spontaneously translocate across the cell membrane.
Therefore, an elegant strategy to design next generation
nanoscopic delivery vehicles is a bottom-up, bioinspired
strategy that mimics naturally evolved systems. Signiﬁcant
scientiﬁc effort, over the past several decades, has resulted in
a large variety of such delivery vehicles including virus-
mimicking protein capsids, lipid- and polymer-based
micelles, lipid- and polymer-based vesicles, and polymer
nanoparticles; each providing speciﬁc architecture and prop-
erties to host biological molecules.6,68–70 The desired biolog-
ical molecules (oligonucleotides, polypeptides, enzymes, and
proteins) can be entrapped, membrane inserted, and/or
attached to the surface depending on their intrinsic physico-
chemical properties, such as shape, hydrophilicity, dipole
moment, charge, ﬂexibility, etc. Preferably, the carriers are
also equipped with a cell-membrane homing moiety, such as
an antibody, a peptide binder, or speciﬁc receptors, designed
to target a speciﬁc cell type.6,14,16,71
Despite signiﬁcant efforts, the most efﬁcient delivery
systems today, based on biomimetic amphiphilic 3D assem-
blies, demonstrate a very low functional delivery efﬁciency.
There are many reasons as to why high-molecular-weight
cargo delivery using artiﬁcial systems does not lead to the
intended functional response in the target cells, all of which
relate to a limited understanding of certain key processes.
For example, although it is an active area of research, it
remains a challenge to control the physicochemical match
required between molecular carrier components and their
drug cargo in order to avoid the uncontrolled release into
nondesired bioregions. Another issue is the lack of under-
standing required to control ligand–receptor dynamics and
geometrical positioning at the interface between nanocarriers
and the cellular membrane in order to induce, for example,
uptake via endocytosis. Another crucial process that must be
successfully controlled in order to generate a functional bio-
logical response is the efﬁcient release of the biological drug
cargo from the endosomes prior to their degradation. Means
to improve this so-called endosomal-escape step are often
considered one of the key bottle necks in improving the per-
formance of drug-delivery nanocarriers, especially for lipid
based systems.3,72
A number of strategies are being explored to develop
more efﬁcient vehicles; one promising approach is to render
polymer-based nanocarriers, in particular, to be stimuli
responsive such that they will release their cargo only upon
changes in the bioenvironment.73,74 Palivan et al. have
developed, as presented at BI 2016, stimuli-responsive syn-
thetic nanoparticles for protein delivery based on asymmetric
poly(ethylene glycol)-b-poly(methylcaprolactone)-b-poly(2-
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(N,N-diethylamino)ethyl methacrylate) (PEG-b-PMCL-b-
PDMAEMA) copolymers that allow both a controlled
entrapment of the proteins and a pH-sensitive release under
variable cellular conditions.75 Such stimuli-responsive vehi-
cles are a signiﬁcant improvement toward optimized func-
tional drug delivery, demonstrating improved temporal and
spatial precision in comparison to conventional delivery car-
riers. However, an important issue to be overcome is the con-
trolled release of payload at the desired biosite when passing
through other sites presenting the same biostimulus.
Advances are expected through efforts to develop appropriate
combinations of stimuli-responsive delivery vehicles and tar-
geting molecular groups for the improved spatial precision in
payload delivery. Furthermore, signiﬁcant improvement in
the efﬁcacy of stimuli-responsive delivery carriers is
expected, beneﬁting from further systematic in vitro and in
vivo assays evaluating the internalization mechanisms, bio-
distribution and release, together with advances in analytical
techniques such as the ones presented herein.
Recently, a complementary strategy to provide a desired
functionality to the cell interior has been introduced by the
design of catalytic compartments, named nanoreactors6,76,77
as well as the ﬁrst examples of artiﬁcial organelles mimick-
ing natural organelles in vitro and very recently in vivo
(Fig. 7).78,79 Nanoreactors are based on encapsulation/entrap-
ment of active compounds (enzymes, proteins, mimics of
proteins) inside supramolecular assemblies such that the
active compounds fulﬁll their activity in situ, without being
released.6,76,77 Particularly appealing for generation of nano-
reactors are amphiphilic block copolymers because, if appro-
priately selected in terms of their chemical nature and
properties, they overcome the instability of liposomes, while
being able to mimic lipid membranes in terms of their low
immunogenicity.80 In addition, it is possible to modulate the
properties of such synthetic compartments (size, stimuli-
responsiveness, permeability) by the intrinsic nature of the
selected copolymers and the hydrophobic-to-hydrophilic
ratio.81 Various nanoreactors have been reported as model
systems, demonstrating a number of reactions that can be
carried out in conﬁned spaces by encapsulated single
enzyme types,76,82 as well as when multiple enzyme types
were encapsulated/inserted in speciﬁc regions of nanocom-
partments [Figs. 7(a)–7(c)].77,78,83 For example, both natural
enzymes, such as laccase, and artiﬁcial ones were shown to
catalyze substrate conversion in the interior of polymer-
somes.82,84 Protein-containing compartments have been
developed for various medical applications including the
production of antibiotics85 or metabolites, as, for example,
glucose-6-phosphate86 as a source of oxygen species for
photodynamic therapy and for oxygen transport and peroxy-
nitrite detoxiﬁcation.87,88 As the chemical reaction is to be
performed in situ (i.e., inside the compartment cavity), a
challenging factor is the permeability of the compartment
membrane to allow a molecular ﬂow through (e.g., for both
substrates to enter the inner cavity and for products to be
released from within). In the quest for selective permeability,
various approaches for obtaining permeable membranes have
been explored including (1) using a block copolymer, which
forms a porous membrane,89 (2) blending block copolymers
with lipids followed by extraction of the latter,90 (3) chemical
modiﬁcation of the membrane to create pores or allow
molecular diffusion,82 and (4) reconstitution of wild-type
channel proteins and genetically modiﬁed proteins to provide
a stimuli-responsive “open”/“close” mechanism to the pores
[Figs. 7(d) and 7(e)].79,91,92
A step further in the development of functional assem-
blies has been achieved by encapsulation of different
enzymes working in tandem inside synthetic compart-
ments in a way that mimics native organelles. The in situ
cascade reactions of artiﬁcial organelles serve to produce
a desired compound or to restore healthy cellular condi-
tions.78,93 Compared to nanoreactors, artiﬁcial organelles
have to be engineered, and their functionality conﬁrmed,
inside cells and in vivo. A ﬁrst example of an artiﬁcial
organelle with functionality that can be switched on by
changes in the cellular microenvironment has been very
recently reported to preserve the architecture and func-
tionality in vivo, in a zebra ﬁsh animal model [Figs. 7(f )
and 7(g)].79
The advantages of this strategy, compared to alternative
systems, include the protection of the active compound from
proteolytic attack and a controlled functionality in the
desired location (e.g., inside cells). Indeed, Palivan presented
a promising example of this strategy, at BI 2016, with the
simultaneous encapsulation of two different enzymes
working in tandem inside a synthetic compartment based on
PMOXA-PDMS-PMOXA combined with the insertion of
membrane proteins into the compartment membrane in order
to mediate the molecular permeability [Figs. 7(a)–7(c)]. In
this way, an artiﬁcial organelle is generated that mimics the
natural peroxisome process occurring inside native cells,
whereby it efﬁciently detoxiﬁes both superoxide radicals and
H2O2 associated with oxidative stress and well known to be
involved in pathologies ranging from cancer to HIV.78 A
step further is achieved if the in situ functionality is triggered
by the presence of a stimulus, such as pH or glutathione.
Such a triggered activity has thus far been successfully
induced by chemically and genetically engineering the mem-
brane proteins to serve as “protein gates” [Figs. 7(d) and
7(e)]. These protein gates open only in the presence of the
desired stimulus and allow a molecular diffusion of sub-
strates and products through the compartment membrane,
which switches on the enzymatic reaction.91,94 This has been
further advanced by engineering stimuli-responsive artiﬁcial
organelles based on simultaneous encapsulation of an
enzyme involved in the cellular redox homeostasis and inser-
tion of a genetically engineered channel porin to serve as a
protein gate that triggers the enzymatic activity inside. As
these artiﬁcial organelles, with triggered activity, preserve
their integrity and remain functional in vivo, in the zebra ﬁsh
animal model, they represent an important advancement
toward the generation of multifunctional systems that will
support the development of personalized medicine [Figs.
7(f ) and 7(g)].79
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A challenging aspect in the development of artiﬁcial
organelles is the efﬁciency of co-encapsulation of different
enzymes inside the compartment such that the resulting
cascade reaction is supported in conditions similar to the
natural organelles. In order to study the simultaneous pres-
ence of multiple enzymes inside the cavity of the nanocom-
partments, the enzymes can be ﬂuorescently labeled and
evaluated using ﬂuorescence cross-correlation spectro-
scopy.78 However, new bioanalytical methods that could
enable the simultaneous detection and quantiﬁcation of the
enzymes inside the compartment are necessary for further
development of the ﬁeld, especially when there are two or
more different types of enzymes, in which case information
about their optimal stoichiometric ratio and the dependence
of relative turnover rates on compartment size is crucial.
Both membrane-loading and encapsulation efﬁciencies are
parameters that are hard to control and often do not follow
what one expects from stoichiometric estimates,95 especially
when taking correlations with nanoassembly size into
consideration.42
Improved information regarding enzymatic heterogeneity,
or the effect of being conﬁned to nanometer range spaces,
may, in future efforts, be obtained by combining functional
(single enzyme) assays with information on structure and
size that can be obtained with the nanopore-based and 2D
ﬂow nanometry concepts described in Secs. II and III,
respectively. In addition, a key point in the functionality of
artiﬁcial organelles is to preserve the activity of the enzymes
inside the compartment, while allowing a rapid release of the
desired products by a controlled permeability. The beneﬁt of
insertion of membrane proteins to render the compartment
membrane permeable, when compared to porous mem-
branes,96 results from the possibility to control the number of
biopores, or even to provide a selective permeability,
depending on the speciﬁcity of the membrane protein, if
required for speciﬁc reactions.94 Therefore, in addition to the
FIG. 7. (a) Schematic representation of artiﬁcial organelles based on an enzymatic cascade reaction taking place inside synthetic nanocompartments equipped
with channel porins, which are (b) up-taken by cells. In (c) real-time reactive oxygen species detoxiﬁcation kinetics of artiﬁcial peroxisomes, in (A) cells
treated with pyocyanin, and (B) cells pre-treated with APs (8 h) followed by treatment with pyocyanin. (d) Schematic representation of artiﬁcial organelles
equipped with biovalve functioning by reversible pore opening and closing inside the membrane of polymersomes to trigger an in situ reaction (left: closed
state; right: open state). (e) Biovalve functionality when inserted into the membrane of horseradish peroxidase (HRP) loaded polymersomes (NRC) after chang-
ing the pH from 7.4 to 6.0, and adding Amplex UltraRed® and H2O2 in each cycle. Green: pH 7.4 and red: pH 6.0. The activities were corrected by taking the
volume increase into account. (f ) Schematic representation of artiﬁcial organelles injected in Zebra ﬁsh animal model. (g) Cellular uptake and intracellular acti-
vation of ﬂuorescently labeled HRP-loaded polymersomes and ﬂuorescently labeled HRP-loaded artiﬁcial organelles. Blue signal: Hoechst 33342 nucleus
stain. Grey signal: CellMask Deep Red-Plasma membrane stain. Green signal: Atto-488 HRP. Red signal: resoruﬁn-like product. Scale bar 20 μm. Adapted
with permission from P. Tanner et al., Nano Lett. 13, 2875 (2013). Copyright 2013, American Chemical Society. Partially adapted from C. Edlinger et al.,
Nano Lett. 17, 5790 (2017). Copyright 2017, American Chemical Society. Also adapted in part from T. Einfalt et al., Nat. Commun. 9, 1127 (2018).
Copyright 2018, Nature. See also Creative Commons Attribution 4.0 International License, https://creativecommons.org/licenses/by/4.0/.
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study of the encapsulated enzymes, the development of bioa-
nalytical tools to characterize the insertion of membrane
proteins, as well as to characterize their structure and func-
tionality inside the compartment membrane, is also expected
to provide key insights and to aid in the optimization of arti-
ﬁcial organelles. Similarly, advancements toward treating
diseases with these novel concepts will also beneﬁt from bio-
analytical techniques that are capable of reporting on the fate
of cellular function upon uptake, such as the ones described
in Sec. V.
V. LIVE-CELL EXTRACTION FOR BIOMOLECULAR
ANALYSES
As previously stated in this review, signiﬁcant emphasis
in contemporary drug discovery is placed on resolving the
tissue and cellular targeting steps of nanoparticles designed
for delivery of large molecular weight drugs, such as pep-
tides, proteins, and oligonucleotides.97 As many of these
drugs act on the intracellular machinery, a means to investi-
gate the molecular content of individual cells, to assess
either the drug’s intracellular level or the cell’s molecular
response upon exposure to the drug, has become increasingly
crucial. Conventionally, the success of targeting, uptake, and
cellular processing has been assessed by ﬂuorescence
microscopy, while cell sorting followed by cell lysis has
been used to analyze the molecular content of cells.97 The
latter approach, however, is limited to the postmortem analy-
sis of cells removed from their physiological context. Using
ﬂuidic force microscopy (FluidFM), Zambelli’s and
Vorholt’s teams demonstrated, at the BI 2016 meeting, how
an AFM-based approach can be used to accurately and
gently drive a nanoscale probe through the cell membrane to
extract tunable amounts of intracellular ﬂuid from live cells
and further that the withdrawn cell contents can be subse-
quently delivered to a variety of analytical techniques for
further analysis.7 In this section, we will discuss the potential
of this new method, as well as a number of other single-cell
approaches,1 to assess the successful delivery of biologicals
to living cells through the analysis of desired readouts.
Cell-based assays are widely used in biological and phar-
maceutical research, providing a valuable intermediate
between biochemical assays and animal studies. While cell-
based assays are routinely performed on large cell popula-
tions, recent technological advances have now made it
possible to scale molecular analyses down to the single-cell
level, opening up a new era in biomedical research.
Multicellular organisms comprise a variety of cell types and
states, with each individual cell interacting with a speciﬁc
microenvironment, and the biochemical processes within
each cell being subject to stochastic ﬂuctuations. In addition,
cells are dynamic systems in which the molecular compo-
nents change in time and space. The resulting cell-to-cell
heterogeneity is imperceptible in classical studies performed
on bulk cell populations, whereby the behaviors of numerous
cells (typically 103–106 cells) are averaged. By contrast,
SCA allow for the elucidation of cell-to-cell variations in
transcripts, proteins, metabolites, and other analytes, thereby
providing the means to study the origins and consequences
of cellular heterogeneity and to investigate cellular state and
function in development, health and disease without an aver-
aging bias.
SCA have already provided invaluable insights into a
variety of research ﬁelds, including developmental biology,
neurobiology, immunology, stem cell, and cancer research.
Notably, single-cell analyses have uncovered somatic muta-
tions in the human genome,98 resolved the cell type compo-
sition of various tissues, discovered previously unknown cell
types,99–101 and identiﬁed subsets of cells implicated in
various diseases.102–104 SCA undoubtedly holds great poten-
tial for drug development. They have already brought new
insights into the molecular mechanisms of different diseases
and have unveiled subsets of cells associated with drug resis-
tance, providing valuable information for the development of
novel therapeutic strategies.105–107 In addition, SCA have
enabled analysis of small molecule drugs and their metabo-
lites in the cell interior, which is where most drugs are tar-
geted.108–111 More generally, SCA provides new means to
evaluate whether a pharmaceutical compound reaches its
action site in sufﬁcient therapeutic concentration, and
whether it engages with its molecular target and triggers the
expected cellular response. At the same time, SCA can
provide valuable information related to the heterogeneity in
drug uptake and molecular response between different
cell types.
While SCA is garnering an increasing interest from the
biological and medical community, the ﬁeld is still con-
strained by technical challenges. Mammalian cells typically
have volumes of 1–5 pl, containing a broad diversity and a
wide dynamic range of cellular analytes. For instance, a
human cell contains more than 10 000 different proteins,
12 000 different transcripts, and 40 000 different metabolites,
present at copy numbers spanning from one up to several
million.112–116 Molecular concentrations in cells are thus
wide ranging but, considering the small volume of a cell,
they typically lie between aM and mM.117 While such con-
centrations do not directly challenge the limit of detection of
current analytical instruments, tools to effectively handle
volumes in the pl–ﬂ range are lacking, and the cellular mole-
cules are usually diluted in current workﬂows. The analysis
of intracellular molecules is therefore an extremely difﬁcult
task that requires the implementation and further develop-
ment of advanced bioanalytical technologies to enable the
detection of low absolute amounts of analytes in complex
mixtures. Moreover, physiological perturbations have to be
minimal during the sampling in order to study unbiased
molecular pools; metabolites, for instance, are highly sensi-
tive to environmental changes and can react within seconds
or even faster. Today, single-cell studies are therefore mostly
focused on nucleic acids because they are relatively stable,
and because ampliﬁcation processes are available that make
it possible to generate a sufﬁcient concentration for further
analysis.118 Another limitation has been that, previously,
SCA were, as schematically illustrated in Fig. 8, commonly
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performed on dead (ﬁxed or lysed) cells separated from their
original tissue or cell culture. Although the dissociation, iso-
lation, and lysis of individual cells can be achieved with high
throughput, the workﬂow imposes important limitations: the
contextual information of the analyzed cell is lost, non-negli-
gible physiological perturbations afﬂict the cell and may
inﬂuence its molecular proﬁle, and the cell is ultimately
sacriﬁced, preventing the collection of complementary data
(e.g., cell behavior). Consequently, the use of SCA for inves-
tigating cell–cell communication, cell response to external
stimuli, or any other spatially or temporally deﬁned biologi-
cal process has been limited.
A promising approach to address these limitations has
emerged through breakthroughs in the nanotechnology ﬁeld
paired with the continuous technological development in bio-
analytics. The alternative strategy, also conceptually illus-
trated in Fig. 8, consists of extracting and analyzing cellular
biopsies rather than whole cells. Despite the decreased
amount of molecules compared to the whole cell content, the
approach is able to preserve cell viability and its physiologi-
cal context, thus offering a means to broaden the potential of
single-cell studies to include the spatially deﬁned and tempo-
ral monitoring of individual cells. Several methods have
been proposed to achieve such nondestructive biomolecular
analyses, relying on the insertion of a minimally invasive
nanoprobe into the cell interior to collect the intracellular
molecules, followed by the transfer of the molecules to a
suitable substrate to perform the downstream molecular anal-
ysis ex situ.
Nanoneedles, either arrayed on a substrate onto which the
cells are cultured or used as individual probes manipulated
externally with a micromanipulator, an AFM, or a magnetic
ﬁeld, represent one type of probe that enables sensing of the
intracellular milieu.119 Their small size provides minimal
invasiveness, high spatial resolution, and high sensitivity
upon insertion into single cells, thus making it possible to
monitor intracellular biomolecules with minimal perturba-
tions. The collection of endogenous molecules using nano-
needles has been achieved through molecular adsorption
onto their surface, which can also be functionalized with
antibodies, for example, to selectively capture a molecule of
interest. Yet, adsorption of biomolecules onto the needle
surface in a complex environment like the intracellular
milieu is a phenomenon that can be neither monitored nor
controlled. Insights into the adsorption kinetics, the local
molecular concentration, or the surface coverage upon
adsorption are unavailable, and the amount of molecules that
can be collected is limited. By ﬂowing the intracellular ﬂuid
into a hollow probe rather than adsorbing molecules on its
surface, the limits, in terms of the quantity and variety of
molecules that are sampled, can, in principle, be lifted.
Singhal et al. immobilized single carbon nanotubes at the
end of glass pipettes that were operated with a micromanipu-
lator.120 With an internal diameter of 50–200 nm, the endo-
scopes enabled the ﬂow of attoliter volumes of ﬂuids
through the probe. The approach is promising for the study
of the intracellular milieu with minimal perturbations;
however, the molecular copy number contained in attoliter
volumes still restricts the analytical options available. More
recently, the Melosh group developed an approach based on
a membrane with an array of hollow 150-nm-diameter nano-
straws on top of which cells could be cultured.121 Upon elec-
troporation, intracellular proteins and mRNAs were shown to
freely diffuse to microliter reservoirs ﬁlled with extraction
buffer on the underside of the membrane. The extracted mol-
ecules were then transferred to the analyzer (ELISA and RT-
qPCR) by a pipette. The approach allowed for multiple sam-
plings of the same cell over time, with more than 95%
FIG. 8. Single-cell analysis. In the standard protocol (left), a cell culture or tissue sample is ﬁrst dissociated to obtain a single cell suspension; the individual
cells are then isolated and ﬁnally dissolved to make their molecular content accessible for the analysis. A problematic issue of this protocol is that the cells are
decoupled from their environment and are no longer viable when analyzed. Alternatively, nanotechnologies such as the FluidFM (right) now make it possible
to sample the cellular content while preserving cell viability and the intercellular interactions.
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postextraction cell viability. In addition, while single nano-
needle probes are restricted to the serial sampling of individ-
ual cells, arrays of nanoneedles hold the potential for
sampling multiple cells in parallel to enhance throughput in
the future. Nonetheless, this promising approach is still
limited in terms of the amounts of molecules that could be
collected and analyzed. Passive diffusion for a few minutes
enabled the collection of an estimated 70 ﬂ, equating to
∼1–7% of a whole cell’s content. The method made it possi-
ble to follow temporal changes in the expression of a ﬂuores-
cent reporter protein with single-cell resolution; however,
qPCR assays to monitor targeted mRNAs required
15–20 cells, whereas enzymatic assays were performed on
∼100 000 cells. With the potential to implement future
advances in bioanalytics and to parallelize the sampling
process, this approach offers great potential for enabling high
throughput molecular analyses of single cells with minimal
disturbance.
Another type of minimally invasive probe that has been
proposed for sampling intracellular molecules is that of glass
micro- and nanopipettes. Glass micropipettes were invented
more than one hundred years ago to address and manipulate
individual cells, mostly in vitro but also in vivo for electro-
physiological experiments.122 With respect to their bioanalyt-
ical application, the Masujima group lead the way with the
“video-mass spectroscope,”123 wherein a glass capillary is
directly inserted into a living cell to withdraw its content and
then positioned as a nanoelectrospray ionization (nano-ESI)
tip in front of a mass spectrometer for the metabolic analysis
of the sampled volume.108,109,124–126 Nanospray microcapil-
laries with inner diameters of 1–5 μm, and operated with a
micromanipulator, have enabled the collection of volumes in
the attoliter to femtoliter range upon application of negative
pressure.123,127 Coupled to ultrasensitive nano-ESI mass
spectrometry, the method succeeded in obtaining differential
metabolite proﬁles from individual cells of different cell
types and could even distinguish the metabolite content of
different cell compartments, thereby identifying granule-
speciﬁc molecules in mast cells. The method also enabled
the measurement of two different drugs and their metabolites
in the cytoplasm, nucleus, and vacuoles of human hepato-
cytes, offering great potential for the investigation of intracel-
lular metabolism and cellular distribution of drugs. The
advent of the scanning ionic current microscope provided a
solution for the critical issue of the controlled approach onto
the optically selected cell by taking advantage of the ionic
current as a feedback signal.128,129 Using scanning ion con-
ductance microscopy (SICM)-operated glass nanopipettes
with an aperture diameter of ∼100 nm, Actis et al. succeeded
in puncturing mammalian cells, collecting samples of cyto-
plasmic ﬂuid by electrowetting, and analyzing both their
mRNA and mitochondrial DNA content while assessing
the cell viability after operation.130 The collected volumes
were estimated to be ∼50 ﬂ (∼1–5% of the whole cell
volume). The glass capillaries used in that study had dimen-
sions approaching those of nanoneedles, thus reducing the
cellular damage, that is, relatively common when using
micropipettes, as evidenced by the cell viability postextrac-
tion of more than 70%. Nanopipette probes are easily pro-
duced from glass capillaries and represent a valuable
alternative to nanoneedles.
AFM pyramidal tips have also been used for nondestruc-
tive sampling of intracellular molecules. Initially, developed
for surface science investigations,131 the AFM has also
proved valuable in a number of biological studies, providing
topographical as well as mechanical information at the
molecular and cellular levels.132,133 Osada et al. demon-
strated how an AFM pyramidal tip can be inserted into the
cell cytoplasm, maintained inside during the time necessary
for the spontaneous physical adsorption of mRNAs onto the
pyramid facets (∼1 min), retracted out of the cell, and ﬁnally
placed into a PCR tube.134 By coating the AFM tip with suc-
cessive conductive and insulating nanolayers of silicon/silica,
an alternating bias can be applied to generate a dielectropho-
retic effect that enables the attraction of nanosized objects.
This phenomenon, sustained by a chemical functionalization
of the AFM tip with appropriate primers, was successfully
exploited by the Wickramasinghe group to increase the
amount of mRNAs captured from the nucleus, which was
then quantiﬁed by qPCR.135 While dielectrophoresis enables
an efﬁcient mRNA enrichment, adsorption of the molecule
of interest onto the probe surface remains, in most situations,
not fully characterized like in the case of nanoneedles.
Furthermore, methods based on the selective hybridization to
chosen primers restrict the analysis to known RNA
molecules.
By enabling the ﬂow of intracellular ﬂuid into an AFM
cantilever instead of adsorbing selected molecules onto its
tip, the recently invented ﬂuidic force microscopy (FluidFM)
provides an attractive alternative to conventional AFM. In
particular, with microchanneled cantilevers, the AFM can act
as a force-controlled pipette that merges the beneﬁts of liquid
exchange (from tens of femtoliters to several picoliters) with
that of the gentle perturbation and nanoscopic precision of
the AFM approach.136 Guillaume-Gentil et al. have demon-
strated, as presented at BI 2016, the collection of intracellular
ﬂuid, from individual cells, into hollow cantilevers upon
application of an under-pressure tip inserted into either the
cytoplasm or the nucleus [Figs. 9(a) and 9(b)]. The appropri-
ate chemical functionalization of the walls of the microchan-
nel to prevent unwanted molecular adsorption as well as to
ensure cell viability after manipulation was comprehensively
considered. The sampled volumes (from 100 ﬂ to 8 pl) were
analyzed with negative-stain transmission electron micros-
copy (cellular nanostructures), qPCR (mRNAs) and enzy-
matic assays (proteins),7 and with matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry
(metabolites) in an ensuing study137 [Figs. 9(c)–9(e)]. The
known channel dimensions and the possibility to observe the
probe by optical microscopy enabled both quantiﬁcation and
tunability of the volumes of intracellular ﬂuid extracted. This
in turn allowed for the assessment of postextraction cell via-
bility as a function of the volume of intracellular ﬂuid
removed, and it was found that more than 80% cell viability
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was obtained after the removal of up to 0.6 pl of nucleoplasm
and up to 4 pl of cytoplasm. While still ensuring cell viabil-
ity, the extraction of relatively large volumes, under pressure
control, facilitated downstream molecular analyses of the
content extracted from single cells. The developed approach
also beneﬁts from the decisive force feedback that enables
the careful dispensing of the extracted samples onto the
matching analyzer substrate (grids, wells, and liquid drop-
lets) without crashing the probe.
The emerging approaches based on cellular biopsies pre-
sented herein (and summarized in Table II) broaden the
potential of single-cell analytics, thereby offering attractive
opportunities for spatially deﬁned and temporal molecular
analyses of living cells in their physiological context. A
major challenge facing the application of these approaches in
biomedicine will be the expansion of the analytical capabili-
ties for going beyond proof-of-principle studies towards
comprehensive omics analysis. Although cellular biopsies
contain smaller absolute number of analytes, and in smaller
volumes compared to entire cells, the massive efforts cur-
rently invested to advance whole cell analysis will also
beneﬁt that of cellular biopsies. Future progress in the ﬁeld
will strongly depend on the development and implementation
of cutting-edge bioanalytical platforms to further lower the
current limits of detection and to achieve more comprehen-
sive analyses of the diverse cellular compounds. While such
FIG. 9. Sampling and analysis of cellular biopsies by FluidFM. (a) Microchanneled FluidFM probe used for collecting cellular biopsies, featuring a 400 nm
aperture (insert). Scale bars are 2 μm and 400 nm, respectively. (b) Harvesting of a cytoplasmic biopsy from HeLa cells expressing green ﬂuorescent protein.
Scale bar is 20 μm. (c) Negative-stain TEM image of extracted cytoplasmic molecules. Scale bar is 200 nm. (d) Fluorogenic assay for caspase-3 activity. The
enzyme activity is detected in the upper right microwell following dispensing of a cytoplasmic extract, whereas the enzyme substrate is not converted in the
three neighboring control wells without cell extracts. Scale bar is 20 μm. (e) Mass spectra of adenosine triphosphate (ATP) from cytoplasmic biopsies of HeLa
cells fed with natural (blue) or 13C-labelled (red) glucose. In part adapted with permission from O. Guillaume-Gentil et al., Anal. Chem. 89, 5017 (2017).
Copyright 2017, American Chemical Society. In part adapted with permission from O. Guillaume-Gentil et al., Cell 166, 506 (2016). Copyright 2017, Elsevier.
TABLE II. Summary of single-cell biopsy technologies.
Nanoneedles Aperture diameter Extraction mechanism Cell compartment
Volumes
collected
Cell
viability
Single-cell molecules
analyzed
Nanoendoscopes 50–200 nm Diffusion Cytoplasm al 100% —
Nanostrawsa 150 nm Diffusion Cytoplasm 70 fl >95% Proteins (RFP)
Glass pipettes
Nano-ESI tip 1–5 μm Pressure-controlled suction Cytoplasm
Nucleus
Vacuoles
al–pl n.a. Metabolites
Nanopipette 100 nm Electrowetting Cytoplasm
Mitochondria
50 fl >70% mRNAs
miDNAs
AFM cantilevers
AFM — adsorption Cytoplasm
Nucleus
— n.a. mRNAs
DENT-AFMb — Dielectrophoresis and adsorption Cytoplasm
Nucleus
— n.a. mRNAs
FluidFM 400 nm Pressure-controlled suction Cytoplasm
Nucleus
100 fl–8 pl >80% mRNAs
Proteins (enzymes)
Metabolites
aFor single cells, arrays of 10 000 nanostraws in a 100 μm× 100 μm substrate.
bDielectrophoretic nanotweezer-AFM.
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technological improvements are expected in the near future,
the different strategies reported herein could already be
applied to investigate biological processes and to assist in the
development of biopharmaceuticals. For example, the mea-
surement of transcripts, enzyme activities, or metabolites is
becoming feasible. Furthermore, breakthroughs in single-cell
bioanalytics, as reported here, could offer critical insights
regarding cellular response after exposure to a biopharmaceu-
tical as well as for the direct measurement of a biological
(e.g., therapeutic oligonucleotides) in the cell interior. With
the exception of nucleic acids, it thus far remains a challenge
to obtain the sensitivities needed to analyze all types of bio-
molecules found in low abundance, and, in particular, to
observe changes in protein concentration. However, the
advancement in single protein analytics reported in this
paper provides reason to be very optimistic regarding future
possibilities to evaluate both the efﬁcacy of different nano-
carriers to deliver the drug into the cell and its potency to,
for example, produce proteins or to inﬂuence their expression
levels.
VI. OUTLOOK
It is obvious that there remains much to be gained from a
continued effort to mimic the elegant solutions that have
evolved in nature, with respect not only to virus-, exosome-,
and organelle-inspired drug-delivery vehicles but also bioa-
nalytical aspects, as here illustrated with methods that make
use of the two-dimensional ﬂuidity of cell-membrane mimics
for protein and nanoparticle characterization. Progress in
these directions will depend strongly on enduring collabora-
tive multidisciplinary enterprises that should, from the start,
match the needs in both academic and clinical settings with
cutting-edge method development. To understand how, for
example, nanoparticle size correlates with charge, shape, or
ligand density, and to understand how such correlations
inﬂuence biological function, it is critical that individual
nanoparticles can also be sorted according to certain prede-
ﬁned ﬁngerprints. In analogy with ﬂuorescence activated cell
sorting (FACS) of individual cells, such techniques should
ideally characterize particles in solution and be sufﬁciently
rapid to provide a decision for sorting. Despite recent
advancements in the ﬁeld, nanoparticle sorting using conven-
tional methods such as ﬁeld ﬂow fractionation138,139 and
ﬂow cytometry140 (which can today offer sensitivities on the
single nanoparticle level approaching that of NTA141) are so
far not compatible with sorting on the single nanoparticle
level. An important contribution that might open up for this
challenging goal was recently demonstrated using so-called
deterministic lateral displacement pillar arrays.142 Thanks to
developments in integrated nanoﬂuidic chip designs, this
concept offers visualization and separation of biological
nanoparticles with dimensions down to a few tens of nano-
meters. Further, the planar design of the chip means that the
nanoparticle could remain in optical focus throughout the
separation step, which suggests that correlation with molecu-
lar content could be feasible. Both the 2D ﬂow nanometry
and the nanopore concepts could, in principle, also be com-
bined with a separation step since microscopic inspection
and real-time analysis of moving nanoparticles can be used
to trigger downstream sorting such that a sorting decision
could be made based on the results from this analysis. To be
practical, however, such an approach would have to operate
in high throughput and would require increased temporal res-
olution of the recordings while maintaining a high signal-to-
noise ratio, improved chip fabrication, advanced computa-
tional algorithms, the ability to combine analysis with fast-
switching ﬂuidics, and to have this all adapted to an array
format supporting hundreds or thousands of particles or
pores. While this collection of required improvements may
sound like a daunting list, rapid advances in micro- and
nanofabrication,143 as well as in the design of integrated cir-
cuits,144 have already accomplished some of these goals and
we are optimistic that signiﬁcant improvements will be made
in the years to come. Essentially such advancement would be
analogous to FACS,145 with the distinction, at least if oper-
ated in label-free mode, that it would be capable of separat-
ing individual molecules or nanoparticles, rather than single
cells, and that the signal for sorting would result directly
from particle properties rather than from a ﬂuorescent label.
It is in this context relevant to recall that progress has been
made in handling tiny amounts of liquids, as well as the
rapid development of tools compatible with advanced single-
cell manipulation (see Sec. V), thus promising that signiﬁ-
cant advances in understanding cellular uptake and func-
tional response can be expected even before the throughput
of such nanoparticle sorting devices has reached the same
level as state-of-the-art FACS. Similarly, a functional under-
standing of the type of artiﬁcial organelles discussed in
Sec. IV would also beneﬁt from this type of single-cell
investigation.
An additional aspect of key importance for single-cell
and single-nanoparticle analytics is the role of the surface
modiﬁcations required for the techniques to function opti-
mally, as all of them stand and fall with how they succeed
in producing the right interface for the investigations. The
ﬂuid coating at the interface utilized for both the 2D ﬂow
nanometry and nanopore concepts is composed of a sup-
ported lipid bilayer made of zwitterionic phospholipids,
which offer several critically important properties. For
instance, its chemical and physical surface properties have
been evolutionarily selected to minimize interactions with
the majority of soluble biomolecules. In fact, the nonadhe-
sive properties of lipid coatings were found to be superior
to any previously reported coatings in nanopores including
those from self-assembled monolayers of PEGylated
alkane thiols on gold.54 Circumventing such nonspeciﬁc
adsorption to the pore walls was the critical prerequisite
for a quantitative analysis of translational and rotational
dynamics since adhesive interactions would lead to arti-
facts in the determined rotational diffusion coefﬁcient,
dipole moment, and charge (see Sec. III). Similarly, too
high an adhesion would render nanoparticles immobile
under 2D ﬂow nanometry analysis, thus excluding size
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determination (see Sec. II). One additional beneﬁt of
coating nanopore walls with an SLB is that the surface
charge of the coating can be tuned by the choice of lipid
headgroups. This capability makes it possible to approach
a surface potential close to zero and thereby to circumvent
electroosmotic ﬂow in the nanopore in the presence of an
electric ﬁeld.146 Since convectional ﬂow through the nano-
scopic constriction of the nanopore is negligible in the
absence of large pressure gradients, the translational
motion of proteins is purely diffusive and electrophoretic.
As an added beneﬁt, bilayer coatings make it possible to
incorporate lipid anchors with afﬁnity towards speciﬁc
analytes. For instance, lipids displaying biotin groups on
their headgroups made it possible to capture, concentrate,
and analyze biotin-binding proteins on the surface, as
demonstrated for both nanopores54 and ﬂow nanometry.147
The well-established streptavidin–biotin coupling strategy
can also be easily extended into sandwich conﬁgurations,
in which lipid-anchored streptavidin binds biotinylated
targets of choice, such as antibodies, protein A/G,
enzymes, and oligonucleotides. Further, Höök’s and
Boxer’s groups have pioneered an alternative strategy,
making use of lipid modiﬁed DNA that self inserts into
lipid membranes.148,149 This enables sequence speciﬁc teth-
ering of DNA-modiﬁed nanoparticles that become mobile at
the lipid membrane interface, given that the number of DNA
tethers is less than around 10–20.150 These strategies,
however, put some limitations on the nature of nanoparticles
that can be analyzed since they require some kind of biomo-
lecular functionalization. However, Cho et al. have shown
that electrostatic attraction can also be used to couple lipid
vesicles in a mobile state on supported membranes,151 sug-
gesting that it will be possible to bind and analyze both poly-
meric and inorganic nanoparticles by varying the charge of
the membrane via the lipid composition. Further, supported
membranes are often used to avoid nonspeciﬁc biomolecular
adsorption to the walls of nanoscale extraction tools, like the
FluidFM probe, as they have been shown to be superior to
many other coatings when handling oligonucleotides in
nanochannels.152 However, if there is no explicit need for a
ﬂuid coating, there are several alternatives, such as the
protein-resistant polymer poly(L-lysine)-graft-poly(ethylene
glycol) (PLL-g-PEG, Surface Solutions GmbH). The non-
fouling properties of PLL-g-PEG coatings are greatly
improved using higher temperatures during the polymer
adsorption on the surface, thereby yielding higher grafting
densities,153 which have been demonstrated very efﬁciently
as a means to reduce nonspeciﬁc adoption to the walls of
nanoscale cellular extraction tools.133 PLL-g-PEG can also
be combined with biotinylated PLL-g-PEG,154 offering the
interesting opportunity to use the inner walls of extraction
probes for selective identiﬁcation of predeﬁned intracellular
target molecules. It is from these examples clear that further
advances in surface modiﬁcation strategies will continue to
play a critical role in the development of both bioanalytical
tools and drug-delivery vehicles, and virtually all aspects of
biomedical devices and materials.
It is also important to stress that it is not only multidisci-
plinary efforts that are needed to bridge existing knowledge
gaps of the type mentioned above, as there are several addi-
tional barriers that must be overcome to successfully trans-
late, for instance, state-of-the-art analytical tools emerging
from physical sciences in engineering settings, to biological,
medical, and pharmaceutical settings. In the case of the
nanopore technology concept presented in Sec. III, it has
indeed been made broadly available, thanks to commerciali-
zation efforts with DNA sequencing in mind.56 However, if
the potential market size is not as large, as in the case of
genetic screening, the investment required for constructing
and successfully launching a sufﬁciently robust and user
friendly tool is often considered too high a barrier. The
ﬂuidic force microscopy concept (FluidFM) presented in
Sec. V is one example of a methodology that, despite this
challenge, has been made available to a broad research com-
munity, and it is indeed our hope and belief that the method
could potentially be an important complement to existing
single-cell manipulation tools. However, in addition to efﬁ-
cient funding schemes, there are many other barriers that
need to be overcome in making academic inventions broadly
available, which together form what is known as the “valley
of death” for small start-up companies. For a general discus-
sion on this topic, we refer the interested reader to the online
interviews that were made with selected speakers at the BI
2016 meeting, and, in particular, Interview 5: Hurdles
impeding progress in the ﬁeld and in the translation of basic
discoveries.155
As mentioned in the interview with Dr. Textor (see the
Appendix), a particularly challenging area that requires
further concerted and interdisciplinary research is in the
study and comparison of single-cell responses in different
culture systems from in vitro studies of cells on surfaces to
co-cultured cells in 3D tissue-model environments that more
closely resemble in vivo. Such 3D model systems were
described during the BI conference, including work by
Dr. M. Lutolf and Dr. B. Rothen-Rutishauser, wherein
methods for creating 3D, highly controlled, microenviron-
ments, and utilizing dynamic materials were presented with
the perspective of both studying and manipulating speciﬁc
disease tissues both in the laboratory and in the body.156–158
We can further foresee that tests of the type of drug-delivery
vehicles that have been highlighted in this review will beneﬁt
importantly from 3D organoids of this nature. Further, the
spatial ﬂexibility of the FluidFM instrument could be, in the
future, further developed into an excellent tool to examine
individual live cells grown in such models. One can also
envision that the very poorly understood, to date, but critical
endosomal-escape step that needs to be overcome for next
generation nucleotide drugs to reach optimal efﬁciency3
could be characterized in detail by using single-cell extrac-
tion to isolate endosomes at different stages of the internali-
zation process, and to use nanoparticle characterization tools
of the type reviewed here to gain information about their
molecular composition and structure at different stages in the
process.
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By having addressed these and related questions in the
context of evaluating progress in the ﬁeld of bioanalytical
advances, we hope to have stimulated further research and
efforts to cross disciplines and bridge the gap between
research in engineering settings, clinical applications, as well
as small start-up companies and well-established biotech and
pharmaceutical industries.
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APPENDIX
Interview with Professor Marcus Textor, Chair of the
inaugural Biointerfaces International Conference,
Zurich, August 2016.
HMG: What prompted the genesis of the Biointerface
International conference and its unique format, which
included a day dedicated to translation of innovation to clinic
and industry?
MT: Our starting point was a small team discussing the
potential need for a conference format that would distinguish
itself from the many types of conferences in the life sciences
ﬁeld including the smaller conferences focused on a speciﬁc
scientiﬁc subject such as the Gordon Conferences and the
much larger professional society type conferences, like the
MRS and ACS. We identiﬁed a need for a medium sized,
international conference with the aim of providing high-level
scientiﬁc talks, covering the most innovative and expanding
topics across the very diverse ﬁelds of relevance to the topic
of biological surfaces and interfaces, and at the same time
making it attractive to attendees from academia, industry and
clinics interested in the translation of scientiﬁc discovery to
markets and clinics. The conclusion was to go for a 3-day
conference that included (1) a three-day single session of
high-level science spanning from bioinspired materials and
bioanalytical tools to 3D cell cultures and regenerative medi-
cine presented by a mix of internationally renowned speak-
ers, early-career scientists and speakers from industry; (2) a
one-day parallel session on translation including a “Science
to Market” component covering pitching science to markets,
start-ups and corporate ventures, followed by a “Science to
Clinics” component addressing some of the difﬁculties in
translation; and (3) a poster session to stimulate discussions
among groups. The hope is that the unique format of this
medium-sized conference, combined with the intention to
identify new communities and latest developments in the
ﬁeld every two years, will ensure that we continue to attract
future participants from the international community in aca-
demia, industry and clinics, across all career levels.
HMG: During the conference, and judging from how you
have seen this ﬁeld develop, did you identify any key areas
as lacking for the future progress in this interdisciplinary
ﬁeld?
MT: Yes, there are many hurdles impeding progress in
the ﬁeld and particularly in terms of translation of basic dis-
coveries to clinical and industrial applications. For instance,
David Mooney, a professor from Harvard University who is
a leading expert in mechano-transduction and new medical
therapies, identiﬁed a need for adjustments in the infrastruc-
ture and funding structure of translational research. The
current funding structure was said to be lacking the move to
ﬁrst-in-man studies or to take innovation through the “last
mile” in translation, also known as the “Valley of Death.”
Funding of, and encouragement of, even wider interdisciplin-
ary approaches and teams to create biologically functional
and translatable constructs such as dynamic functional
systems and organoid structures, for both diagnostic applica-
tions, e.g., drug screening, toxicity, disease monitoring, as
well as for applications in targeted drug delivery and regen-
erative medicine, is needed. Validation as to whether the
resulting data truly represents human biology or whole body
biology remains to be shown, however, and this pursuit will
beneﬁt from quantitative bioanalytical tools that can, for
example, enable the study and comparison of single-cell
responses in different culture systems from 2D to 3D.
Furthermore, it was noted that future progress in the wider
ﬁeld of biomaterials would depend on the development and
accessibility of the increasingly sophisticated technology
required to probe the many relevant biointerfaces including
those found in both biological and synthetic nanoparticles.
HMG: The notion of bioinspired solutions and biomimi-
cry came up frequently during the conference; what are your
thoughts on the current state of the art and future directions
when taking nature as our guide?
MT: For me this is one of the most exciting and promis-
ing ﬁelds in materials science. It’s an unlimited source of
inspiration. Bioinspiration has resulted in a number of func-
tional materials, interfaces and devices, when scientists have
either chosen concepts wherein natural materials or compo-
nents are used, e.g., self-assembled systems such as multi-
functional lipid vesicles, biological nanoparticles, or where
artiﬁcial systems are used to mimic, as closely as possible,
native mechanisms or functions. With the latter, biomimicry
systems or devices can in principle be based on a great
variety of designed materials, such as stable supported
polymeric membranes for surface-sensitive sensing and poly-
meric vesicles as nanocontainers. Native material constructs
have the advantage of exploiting very efﬁcient natural path-
ways, often difﬁcult to mimic by artiﬁcial materials, and
require, in general, reduced regulatory effort. An additional
very important objective for this conference was to show the
latest concepts and achievements in this competitive ﬁeld
towards applications in bioanalytics and clinical diagnostics
with unprecedented sensitivity (e.g., single protein analysis,
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single nanoparticle characterization) as well as towards
advanced solutions for drug delivery. A common challenge,
as speciﬁcally addressed by hosting a translation session,
will be a means to successfully transfer these new technolo-
gies towards clinical evaluation and practice, and their vali-
dation as reliable tools.
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